et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 532–55.
et al. A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases. Ann. Gen. Psychiatry 2008; 7: 7.
Depression and COPD in older people: a review and discussion. Br. J. Community Nurs. 2005; 10: 42–6.
Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2008). 2010.
National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. 2010.
National Institute for Health and Clinical Excellence. CG91 Depression with a Chronic Physical Health Problem: NICE Guideline. National Collaborating Centre for Mental Health, London, 2009.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC, 2000; 401–10.
Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. Am. J. Psychiatry 2006; 163: 872–80.
, , .
et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008; 134(4 Suppl.): 43S–56S.
Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999; 54: 688–92.
, , .
et al. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am. J. Med. 2009; 122: 778.e9–15.
et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002; 57: 412–16.
et al. The association between depressive symptoms and acute exacerbations of COPD. Lung 2009; 187: 128–35.
et al. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006; 11: 188–95.
et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch. Intern. Med. 2007; 167: 60–7.
Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom. Med. 2003; 65: 963–70.
Mental disorders in chronic obstructive pulmonary disease (COPD). Respir. Med. 2008; 102: 764–73.
Comorbidity of depression and panic disorder. J. Clin. Psychiatry 1996; 57(Suppl. 10): 34–41.
Panic disorder as a chronic illness. J. Clin. Psychiatry 1997; 58(Suppl. 13): 5–8.
et al. Self-reported anxiety, general medical conditions, and disability bed days. Am. J. Psychiatry 1997; 154: 1766–8.
Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen. Hosp. Psychiatry 2001; 23: 77–83.
Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int. J. Geriatr. Psychiatry 2000; 15: 1090–6.
, , .
Dyspnea, anxiety, and depression in chronic respiratory impairment. Gen. Hosp. Psychiatry 1992; 14: 20–8.
, , .
et al. Qualitative aspects of breathlessness in health and disease. Thorax 2009; 64: 713–18.
et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159: 896–901.
Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 164: 770–7.
, , .
et al. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br. J. Psychiatry Suppl. 1996; 30: 17–30.
The burden of depression and anxiety in general medicine. J. Clin. Psychiatry 2001; 62(Suppl. 8): 4–9.
National Institute for Health and Clinical Excellence. NICE Clinical Guideline 22 Anxiety (Amended): Management of Anxiety (Panic Disorder, with or without Agoraphobia, and Generalized Anxiety Disorder) in Adults in Primary, Secondary or Community Care. National Institute for Health and Clinical Excellence, London, 2007.
National Institute for Health and Clinical Excellence. Depression in Adults with a Chronic Physical Health Problem: Treatment and Management. National Institute for Health and Clinical Excellence, London, 2009.
National Institute for Health and Clinical Excellence. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults-management in primary, secondary and community care. NICE clinical guideline 113. 2011.
et al. Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: 2606–10.
Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction 2006; 101: 1814–21.
Depression during tobacco abstinence. Nicotine Tob. Res. 2011; 9: 443–6.
et al. Helping smokers with depression to quit smoking: collaborative care with Quitline. Med. J. Aust. 2011; 195: S7–11.
et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 2008; Issue 1, Art. No. CD000146.
Non-nicotinic therapies for smoking cessation. Annu. Rev. Pharmacol. Toxicol. 2007; 47: 541–64.
Antidepressants for smoking cessation. Cochrane Database Syst. Rev. 2007; Issue 1, Art. No. CD000031.
, , .
et al. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur. Respir. J. 2009; 34: 634–40.
A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat. Med. 2004; 18: 558–63.
, , .
et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 2000; 284: 2907–11.
et al. Palliative care in chronic obstructive airways disease: a needs assessment. Palliat. Med. 1998; 12: 245–54.
How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000; 55: 1000–6.
, , .
Palliative care provision for patients with chronic obstructive pulmonary disease. Health Qual. Life Outcomes 2007; 5: 17.
et al. End-of-life content in treatment guidelines for life-limiting diseases. J. Palliat. Med. 2004; 7: 754–73.
et al. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat. Med. 2005; 19: 485–91.
et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006; 173: 1390–413.
et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000; 41: 465–71.
American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am. J. Psychiatry 2000; 157(4 Suppl.): 1–45.
et al. Psychological interventions for multiple sclerosis. Cochrane Database Syst. Rev. 2006; Issue 1, Art. No. CD004431.
et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 2001; 357: 841–7.
Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int. J. Psychiatry Med. 2006; 36: 13–34.
, , .
A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. J. Nerv. Ment. Dis. 2007; 195: 521–31.
Cognitive-behavioral treatment for panic disorder: current status. J. Psychiatr. Pract. 2004; 10: 211–26.
Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: a systematic review of cognitive behavioural therapy. Br. J. Health Psychol. 2008; 13(Pt 3): 381–400.
et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol. Med. 2008; 38: 385–96.
Prevention of panic attacks and panic disorder in chronic obstructive pulmonary disease. Eur. Respir. J. 2010; 35: 557–63.
, , .
A meta-analysis of randomized trials of behavioural treatment of depression. Psychol. Med. 2008; 38: 611–23.
, , .
et al. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2011; (11): CD008483.
et al. Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch. Intern. Med. 1986; 146: 1377–80.
et al. Effect of desipramine on control of ventilation and depression scores in patients with severe chronic obstructive pulmonary disease. Psychiatry Res. 1985; 15: 25–32.
et al. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD 2005; 2: 233–41.
et al. Pilot study to examine the effect of citalopram on health status, anxiety and depression in patients with chronic obstructive pulmonary disease. clinicaltrials.gov 2004. [Accessed 27 April 2010.] ., ,
et al. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch. Chest Dis. 2004; 61: 140–7.
Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients. Int. Clin. Psychopharmacol. 1998; 13(Suppl. 5): S49–54.
The cytochrome p450 homepage. Hum. Genomics 2009; 4: 59–65.
Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol. 2008; 21: 70–83.
Prescribing for Elderly Patients. John Wiley & Sons, Ltd, Chichester, 2009.
, , .
Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol. Ther. 2000; 85: 11–28.
Australian Medicines Handbook 2010. Australian Medicines Handbook, Adelaide, 2010. , ed.
Clinically significant drug interactions with antidepressants in the elderly. Drugs Aging 2002; 19: 299–320.
et al. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 1992; 33: 190–201.
et al. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual. Life Outcomes 2008; 6: 46.
et al. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 1998; 39: 24–9.
et al. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest 1993; 103: 800–4.
Psychotropic Expert Group. Therapeutic Guidelines: Psychotropic. version 6 updated edn. Therapeutic Guidelines Ltd 2008, Melbourne, 2009.
Management of anxiety and depression syndromes in the elderly. J. Clin. Psychiatry 1994; 55(Suppl.): 5–12.
Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review. Hum. Psychopharmacol. 2003; 18: 185–90.
The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin. Neuropharmacol. 2005; 28: 205–14.
SSRIs and the syndrome of inappropriate antidiuretic hormone secretion. Am. J. Nurs. 2007; 107: 51–8.
Fluvoxamine-methadone interaction. Aust. N. Z. J. Psychiatry 1999; 33: 99–101.
et al. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf. 2009; 32: 1041–56.
et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch. Intern. Med. 2007; 167: 188–94.
et al. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am. J. Epidemiol. 2003; 158: 77–84.
Fracture risks of antidepressants. Expert Rev. Neurother. 2009; 9: 137–41.
et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157(6 Pt 1): 1791–7.
Antidepressant and benzodiazepine for major depression. Cochrane Database Syst. Rev. 2002; Issue 1, Art. No. CD001026.
, , .
Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2008). 2008. Medical Communication Resources.
et al. The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003. Med. J. Aust. 2003; 178(Suppl.): S7–39.
et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura. Medicophys. 2007; 43: 475–85.
Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J. Psychosom. Res. 2007; 63: 551–65.
Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Curr. Opin. Pulm. Med. 2009; 15: 143–9.
et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004; 329: 1209.
The relaxation response. Psychiatry 1974; 37: 37–46.
, , .
et al. The efficacy of relaxation response interventions with adult patients: a review of the literature. J. Cardiovasc. Nurs. 1996; 10: 4–26.
Meta-analysis of the effects of psychoeducational care in adults with chronic obstructive pulmonary disease. Patient Educ. Couns. 1996; 29: 167–78.
Clinical practice. Palliative care. N. Engl. J. Med. 2004; 350: 2582–90.
et al. Outcome evaluation of a randomized trial of the PhoenixCare intervention: program of case management and coordinated care for the seriously chronically ill. J. Palliat. Med. 2006; 9: 111–26.
New Applications of Interpersonal Psychotherapy. American Psychiatric Press, Washington, DC, 1993. , .
et al. Interpersonal counselling in general practice. Aust. Fam. Physician 2004; 33: 332–7.
Interpersonal psychotherapy: principles and applications. World Psychiatry 2004; 3: 136–9.
et al. A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder. Depress. Anxiety 2008; 25: 542–53.
Using interpersonal therapy (IPT) with older adults today and tomorrow: a review of the literature and new developments. Curr. Psychiatry Rep. 2008; 10: 16–22.
et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch. Intern. Med. 2003; 163: 585–91.
et al. Promotion of self-management in vulnerable older people: a narrative literature review of outcomes of the Chronic Disease Self-Management Program (CDSMP). Eur. J. Ageing 2009; 6: 303–14.
et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 2009; 301: 2099–110.
et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2007; Issue 4, Art No. CD002990.
et al. Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009; 64: 956–62.
et al. Controlled trial of respiratory health worker visiting patients with chronic respiratory disability. Br. Med. J. (Clin. Res. Ed) 1987; 294: 225–8.
Organizing care for patients with chronic illness. Milbank Q. 1996; 74: 511–44.
, , .
et al. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch. Gen. Psychiatry 2005; 62: 1332–41.
et al. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. Med. Care 2004; 42: 1211–21.
et al. Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2003; Issue 4, Art. No. CD003573. , ,
et al. Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. Eur. Respir. J. 2003; 21: 58–67.
et al. Substitutive ‘hospital at home’ versus inpatient care for elderly patients with exacerbations of chronic obstructive pulmonary disease: a prospective randomized, controlled trial. J. Am. Geriatr. Soc. 2008; 56: 493–500.
Clinical Manual of Supportive Psychotherapy, 1st edn. American Psychiatric Press, Washington, DC, 1993. , , .
Supportive Therapy Treatment Manual. Social and Behavioral Sciences Documents, Corte Madera, CA, 1988. , .
et al. Evidence-based psychological treatments for late-life anxiety. Psychol. Aging 2007; 22: 8–17.
The transformation of social representations of chronic disease in a self-help group. J. Health Psychol. 2003; 8: 599–615.
Issues in the study and application of social support. In: Cohen S, Syme LC (eds) Social Support and Health. Academic Press, New York, 1985; 3–22. , .
Self-help groups for patients with coronary heart disease as a resource for rehabilitation and secondary prevention-what is the evidence? Heart Lung 2009; 38: 192–200.
, , .
Self-help groups: their impact and potential. WHO Reg. Publ. Eur. Ser. 1992; 44: 363–7.